Top Medical News

Diabetes Linked With Increased Levels of Neurofilament Light, Neuroaxonal Damage in Parkinson Disease

August 10, 2022

By Marco Meglio

Investigators identified increased levels of neurofilament light that corresponded significantly with patients’ diabetic status, even after adjustment for age, BMI, and vascular risk factors.

NeuroVoices: Vesna Garovic, MD, PhD, on Severe Preclampsia’s Effect on Late-Life Cognition, Neuroinflammation for Women

August 10, 2022

By Marco Meglio

The chair of the nephrology division at Mayo Clinic provided context on new findings on the risks of preeclampsia, a hypertensive disorder, and elevated levels of neuroinflammation and neurovascular damage.

FDA Extends Review of Omaveloxolone in Friedreich Ataxia

August 09, 2022

By Matt Hoffman

After Reata Pharmaceuticals submitted an analysis from the MOXIe extension study of the investigational agent as part of the NDA submission, the FDA extended the PDUFA date to February 2023.

Pepinemab’s Upregulation of SEMA4D Expression Warrants Further Development in Huntington, Alzheimer Disease

August 09, 2022

By Marco Meglio

In a phase 2 trial, pepinemab significantly improved metabolic activity as detected by FDG-PET in the majority of brain regions examined, as well as correlated with changes in cognition across both Huntington disease and Alzheimer disease.

Future Relapse Remission in Multiple Sclerosis Impacted by Retinal Layer Thinning

August 09, 2022

By Marco Meglio

The impact of retinal thinning was higher when using GCIPL rather than pRNFL thinning as it explained more of the variance in relapse remission.

Featured

Mind Moments Podcast

Click here to listen to Mind Moments™, a podcast from NeurologyLive® that brings you exclusive interviews with expert neurologists and clinicians.

NeuroVoices

Click here to read NeurologyLive®'s NeuroVoices series of in-depth, exclusive conversations with a variety of experts in the care and management of patients with neurologic diseases about topics in clinical care and therapeutic development.

Coverage of the Advanced Therapeutics in Movement and Related Disorders Congress

Get the latest data and clinical news updates, as well as interviews with experts, straight from the conference floor.

Gold Standard Centers

Click here to check out the latest deep dive into examples of institutional success in medicine with our Gold Standard Centers feature series.

Brain Games

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics.

EEGTalk

EEGTalk is a series dedicated to teaching EEG reading skills in neurology in a way that is both digestible and fun, hosted by Fábio A. Nascimento, MD, and Brandon Westover MD, PhD. Click here to watch.

Latest Videos

Peers & Perspectives: The Induction vs Escalation Approach to MS and the TREAT-MS Trial

Novel Oral Treatment Selection in RRMS

Comparing Reactive Microglia and Astrocytes in Secondary Progressive Multiple Sclerosis

Redefining, Simplifying the Complexities of Alzheimer Disease and Amyloid Cascade: Ralph Nixon, MD, PhD

Using Functional Connectivity and the Default Network to Uncover Sex-Based Differences: Jessica Caldwell, PhD

The Wide-Reaching Impact of Multiple Sclerosis DMT Wastes: Darin T. Okuda, MD; Karin Cook

Recognizing Lysosomal Autophagy as a Realistic Target for Alzheimer Disease: Ralph Nixon, MD, PhD

Incorporating Voice Analytics Into Cognitive Assessments: Alvaro Pascual-Leone, MD, PhD

Getting Up to Speed on the Evolving Landscape of Multiple Sclerosis: Annette Okai, MD

Severe Preeclampsia Linked With Neuroinflammation, Neurofilament Light Associated With Memory Function, Discrimination Effects on Cognition

The Mount Sinai Perspective on the State of MS Care: Stephen Krieger, MD

Understanding the Neuropathological Link Between Preeclampsia and Neuroinflammation, Neurovascular Damage: Vesna Garovic, MD, PhD

Using Nonamnestic Cognitive Symptoms to Predict Trajectories of Neurodegenerative Disorders: Jagan A. Pillai, MD, PhD

Most Recent

Using the Cognitive Stress Test to Distinguish Pre-MCI and Amnestic MCI: Leeron Nahmias, BS

August 09, 2022

Video

The medical student at Nova Southeastern University provided insight on a new innovative tool called the Cognitive Stress Test that can help distinguish different cognitive states for older adults. [WATCH TIME: 6 minutes]

Delayed Diagnosis of Functional Seizures Associated With Abnormal Processing of Face Emotions

August 09, 2022

Article

Increased posterior cingulate cortex activation to sad faces in the long-delay diagnostic group were associated with worse symptoms of depression, as expressed by Beck Depression Inventory scores.

Migraine and Mental Health: Taking Time to Ask the Questions

August 08, 2022

Article

Lawrence Newman, MD, offered his insight into the findings of a survey conducted by the American Headache Foundation that identified correlations between migraine and mental health conditions.

Understanding Cognition and Brain Health in Multiple Sclerosis

August 08, 2022

Video

Ahmed Obeidat, MD, PhD; Randall Schapiro, MD, FAAN; and Jeffrey Wilken, PhD, comment on early investigations surrounding the impact of multiple sclerosis on cognition and brain health and the current lack of focus regarding its impact on patients.

Evolution and Prevalence of Multiple Sclerosis

August 08, 2022

Video

Ahmed Obeidat, MD, PhD; and Randall Schapiro, MD, FAAN, discuss the prevalence of multiple sclerosis and highlight how the disease has evolved since they began practicing. They also review the impact it has on patients and their support communities.

Characteristics of Bilateral Parafalcine Cortical Leptomeningeal Impairment in NMOSD, MOGAD Identified to Avoid Misdiagnosis

August 08, 2022

Article

BPCLI was observed in both NMOSD and MOGAD but was relatively rarer in AQP4 NMOSD, with meningoencephalitis-like episodes among the sources of misdiagnosis.

This Week on NeurologyLive® — August 8, 2022

August 08, 2022

Article

Here's some of what is coming soon to NeurologyLive® this week.

ICER Releases Report Comparing Cost-Effectiveness of ALS Agents Oral Edaravone and AMX0035

August 07, 2022

Article

After recently receiving approval in Canada, AMX0035 looks to join the US market alongside riluzole and edaravone, the only FDA-approved therapeutics that slow disease progression in ALS.

NeurologyLive® Brain Games: August 7, 2022

August 07, 2022

Article

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is neuromyelitis optica spectrum disorder.

Using Initial Cognitive Symptoms to Predict Trajectories of Neurodegenerative Pathologies

August 06, 2022

Article

Jagan A. Pillai, MD, PhD, neurologist, Cleveland Clinic Lou Ruvo Center for Brain Health, discussed a recent study which found faster clinical progression in those with nonamnestic initial cognitive symptoms.

Latest SAP Content

Redefining, Simplifying the Complexities of Alzheimer Disease and Amyloid Cascade: Ralph Nixon, MD, PhD

Brainwaves - Spring Issue

Using Functional Connectivity and the Default Network to Uncover Sex-Based Differences: Jessica Caldwell, PhD

NeuroVoices: Vesna Garovic, MD, PhD, on Severe Preclampsia’s Effect on Late-Life Cognition, Neuroinflammation for Women

View More SAP Content